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?hCe the initiai pe~ormancc Of Percuta~eQU~ il.dtlShllillii~ 
coronary ~~g~opla5~y in 1977 (I ,2), in ications for this pro- 
cedure have progressively broadene to include patients 
with multive disease, diminished left ventricular function 
and acule is mic syndromes (3-14). A~tho~gb the inter- 
ruption of anterograde coronary blood flow during balloon 
inflation is well tolerated by most patients, some with more 
extensive disease and limited coronary reserve may be 
intolerant of even small degrees of added ischemia. Several 
innovative support techniques have recently been developed 
and have progressed along three principal lines. The benefits 
of ventricular unloading and augmented coronary perfusion 
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accesl and support iscbemic myo ium, either through 
e current study, evaluation of 
of th.: retroperfusion technique has r 
utilizes longer angioplas 
Between June 18, I990 and October 18, 199a). 30 consec- 
utive patients undergoing high risk angio 
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General Hospital were enrolled in the study. Entry crhia 
hcluded a target lesion of ~70% diameter stenosis in a 
coronary artery supplying 240% of the viable myocardium 
or a left ventricular ejection fraction ~45%, or both. EXC~U- 
sion criteria included the presence ofongoing ischemia at the 
onset of the procedure (angina with or without electrocar- 
diographic [ECG] changes), the presence of significant an- 
giographic collateral flow to the target vessel, overt conges- 
tive heart failure, cardiogenic shock, severe valvular heart 
disease or the inability to obtain high quality transthoracic 
echocardiographic images. The latter was assessed before 
patient enrollment. The presence ofcomplete bundle branch 
block was not an exclusion criterion. All patients had 
undergone diagnostic coronary atteriography within 7 days 
before angioplasty. Global eft ventricular ejection fraction 
was calculated using the area/length method of right anterior 
oblique ventriculograms (44). Assessment of the severity of 
coronary artery lesions was measured in blinded manner by 
three xperienced *n.rrgtographers by the consensus method. 
The study protoci>l was approved by our Human Investiga- 
tions Institutional Review Board, and informed consent was 
obtained from all patients. 
Edison system. The retroperfusion system (Ret- 
roperfusion Systems Inc.) consists of three principal com- 
ponents: an 8F catheter with end and multiple side holes to 
harvest arterial blood, a piston-driven lectrocardiographic 
(ECG) R wave-triggered pumping console and the triple- 
iumen coronary sinus retroperfusion catheter (40,43). Gas 
(carbon dioxide) inflation of the coronary sinus balloon is 
synchronized with diastole, resulting in coronary sinus oc- 
clusion and allowing retrograde infusion of arterial blood. 
Rapid balloon deflation in systole allows for coronary ve- 
nous drainage in the usual fashion. A third port provides 
continuous pressure manometry. Coronary sinus retroperfu- 
sate flow rate is adjustable to a maximum of 250 mllmin. 
Coronary ioplasty protod. All study patients re- 
ceived aspirin, dipyridamoie and a calcium chanuei autago- 
nist for at least 24 h before the procedure. Standard femoral 
artery and vein sheaths were placed on one side. An 8F 
arterial sheath was placed in the contralateral femoral rtery 
for accessing oxygenated blood. The right internal jugular 
vein was used for coronary sinus access in the first 20 
patients. In the final 10 patients, access from the femoral 
vein was accomplished utilizing a Simmons II or III 7F 
catheter before guide wire exchange for the retroperfusiou 
catheter (45). All patients received 10,000 U of neparin 
intravenously, with the activated clotting time maintained 
between 360 and 480 s. The preferred retroperfusion catheter 
position was the great cardiac vein (43); however, difficulty 
in initially accessing the great cardiac vein or problems with 
subsequent catheter migration i to the coroaary sinus re- 
sulted in a proximal catheter position in I I patients. 
patients were randomized to receive coronary sinus ret- 
roperfusion Support during either the second or the third 
angioplasty balloon inflation, after an initial brief nonran- 
domized (unsupported) inflation. Th s procedure was fol- 
lowed to lessen the i 
subsequent i &&ions. 
provided between each of the three inflations. 
recovery period, the diastolic synchronizes retro 
flow rate was initiated at 5 ml/mitt o rna~~tai~ 
patency, Immediately befo 
initiated at 50 ml/mm an ~creme~tally increased to a 
systolic oronary sinus 
as the duration o
duration of either randomize ioplasty balloon inflation. 
The dara~jon of’ each angl ry balloon ~~~Q~~o~ was 
determined bythe first operator (based on the usual clinical 
variables, including angina, ST segment deviation 
modynamic compromise) but not allowed to excee 
Procedural success was de 
stenosis of the target lesion and the absence of acute 
myocardial infarction, cardiogenic shock, emergency oro- 
nary artery b pass grafting or death. 
Severity, duration and time to on angina were 
recorded for all three angioplasty balloo ions. Fatients 
reported their angina on a scale of 0 (no pain) to 10 (
pain) in blinded fashion. Hemodynamic variables (heart rate, 
mean arterial blood peessure, systolic blood pressure and 
mean and maximal c ure) were continu- 
re and 
and at 
300 s after the onset of coronary occlusion. Red blood cell 
count, hemoglobin, hematocrit, pl t count, plasma free 
hemoglobin, creatine kinase with fraction, serum glu- 
tamic oxaloacetic transaminase and lactic de 
values were al! obtained immediately before, immediately 
after and 24 hafter the procedure. 
. A 1Zlead ECG was recorded 
on a Mortara ELI 1 ST interpretive electrocardiograph 
(Mortara Instruments) in the catheterization laboratory at 
baseline. immediately before ach angioplasty balloon infla- 
tion, al peak inflation time and every 28 s during each 
inflation. The absolute magnitude of ST deviation was re- 
corded at 0.06 safter the J point for each of the 12 leads. .ihe 
magnitude of ST deviation recorded inthe baseline ECG was 
subtracted from the magnitude of the ST deviation that 
occurred uring the retroperfusion-supported and unsup- 
ported balloon inflations. This procedure provided the abso- 
lute magnitude of ST deviation developed during the respec- 
tive inflations. The differences were summated toprovide a 
single score for each randomized inflation. Data analysis was 
performed in blinded manner by an independent core labo- 
ratory. 
Echocardiography. Two-dimensional echocardiograms in 
the apical four-chamber view with the patient in the supine 
JACC Vol. 22. No. 1 
My 1993:127-34 
nritative metbo~ was 
descending wall motion score at similar 
ables of interest were corn 
t test. Given that these 
statistically using the paire 
bles may not be ~ormal~ 
t test results are ported for ease of interpretation. 
Laboratory variables were evaluate 
repeated measures analysis of variance. 
left anterior descending wall motion score change from base- 
line over the course of the coronary sinus retroperfusion- 
supported and unsupported balloon inflations were also 
tested statistically using repeated measures analysis of vari- 
ance (ANCWA) for unbalanced rn~de~s. A two-way model 
was used, allowing for a statistical ssessment of the grou 
(i.e., supported versus unsupported), time and gr 
effects. All data are expressed as mean value -C 
Coronary sinns ~theterizat~o~ me. Coronary si- 
nus catheterization was successfolly performed in 26 (87%) 
character~st~cs of the 
the study protocol ar 
target lesions involve 
roximal portion, nine in 
ients with left internai c
a~ast~rn~t~c lesi 
coronary artery, w 
anterior desce~d~~~ c 
one non-left anterior 
. ---I--&.,4,.. _ “..I*” Tk.3 nnmn~n, anninnlactv nrnrp&l~e NllgllDrJWSJLJ L=JP1IW. 1 ‘I& bU.“I‘U. > ..pvgd...-_, r‘-“-‘ 
was successfully performed on 22 of the 24 coronary artery 
lesions (92% success rate). There were no total occhrsions 
included as target lesions. Angioplasty re ulted in a reduc- 
tion in mean percent diameter stenosis of the target lesion 
87 k 19% before angioplasty o 29 2 15% after 
atigioplasty. The mean duration of inflation was 129 2 87 s 
at baseline was 8 + 4 an 
both). The mean change in mean and maximal SYStOlic 
coronary Sinus pressure from baseline to supported infla- 
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Hemodynamic Variables Unsupported Supported 
Index time (124 + 90 s) 
HR (beatslmin) (n = 22) 76k 14 74k I? 
MAP (mm Hg) 92 ?I 24 94 2 23 
139 ” 36 135 + 39 
Angina score tn = 1% 4z3 423 
Angina1 episodes (n = 19) 18 18 
129 L 87 173 i- 96 
77? 16 75 2 20 
87 2 26 93 + 24 
SBP (mm Hg) 139 f il! 137 c 39 
Angina score (II = 19) 5 k;i 524 
Anginal episodes (n = 19) - - :i 17 
Time to onset of angina (s) 71 246 67 + 23 
CS pressure (mm Wg) (n = 22) 
Mean to 2 4 II i:6 
Maximal systolic I6 + 5 44+ 13 
p Value 
NS 
NS 
NS 
NS 
0.004 
NS 
?!S 
NS 
NS 
NS 
i 0.001 
< 0.001 
‘Three patients experienced no angina. Values are expressed as number 
or mean value k SD. CS = coronary sinus; HR = heart rate: MAP = mean 
arterial blood pressure: SBP = systolic blood pressure. 
g, respectively. TRe mean 
+ 38 mllmin (range 85 to 
There was no d ence in the occurrence rate, 
na between the u~suppo~ed 
n analyzed at the index time 
and peak inflation time (n = 19) (Table 2). Three patients 
who did not experience angina during coronary angioplasty 
balloon inflations were excluded from angina nalysis. None 
of these three patien 
Dlarv Glll9 rptroCerf~lsion-surpF!Pd wild unqqKM?ed cnn- , 1----- 
ditions when com~a~ng mean heart rate, mean arterial blood 
pressure and mean systolic blood pressure at both index and 
For technical reasons, ECG 
patierts, who were therefore 
eliminated from further KG analysis. The absolute magni- 
tude of ST deviation recorded from the I2 leads was 15.8 2 
3.0 mm during supported angioplasty inflations, compared 
with 16.1 c 3.1 mm du’ring unsup rted inflations (p = NS). 
Although, as a group, supported i ations were significantly 
longer than unsupported in rations, they ‘were associated 
G evidence of ischemia. 
One patient with a middle obtuse 
lesion was excluded from echocar- 
e rrmaining 211 patients had myocar- 
dium in jeopardy in the left anterior descending coronary 
artery distribution. 
Corrected wall motion score (Fig. I). The change in left 
left anterior descending artery 
S) change from baseline as a fumnc 
ofl-~~pp~rt~~ balloon angioplasty Bsg 
with values with unsupported aragioplasty 
I ; time effec?, p = 0.01 (repeated 
of variance (ANOVA). 
anterior descending wall motion fro 
rected wall motion score) at each eim 
owing us to renort a 
poried infiatians. These mean correce 
on baseline were then 
progression of wall 
deterioration of corrected wall motion score with time iea 
eated measures ANOVA 
revealed a group etfect in which the supposed ideations 
exhibited a lesser degree of deterioration i  c 
score from baseline than unsupported i 
0.001). Additionally, each patient’s corrected wall motion 
score curve was summated over time to 
wall motion score. The aggregate mean 0 
supported and u~suppo~ed in~atio~s was 1.8 5 1.7 and 
I .4, respectively (Q < 0.02). 
~C~~C~~~~~~ia~~~C interrogation was 
e for all 21 patients was 1.7 4 2.1 
. There was no ev 
when comparing preprocedure, immediate postprocedure or
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24-h postprocedure values. Respectively, those mean values 
for plasma free hemoglobin were 0.01 r”l 0.01, 0.01 & 0.01 
and 0.07 + 0.25, and for laWltb urrlJariU n*‘n Aah**Ai-genase they were 
178 f 15, 191 +82 and 192 + 72 (p = 
This study demonstrates that s cbronized coronary si- 
nus retroperfusion effectively delays the davelopment and 
limits the extent of myocardial ischemia nmoderate ohigh 
risk coronary angioplasty. 
In 1898, Pratt (48) first documented tkat myocardium can 
be supported exclusively through rPtro$radP delivery of 
defibrinated blood. Subsequently, Roberts et al. (49) and 
Beck and colleagues (50,51) directly anastomosed arterial 
grafts to the coronary sinus; although the procedure effec- 
tively revascularized the heart. its long-term efficacy was 
limited by the development of cardiac edema resulting from 
insufficient venous drainage. Thus, inte 
techniques languished until 1975, when 
introduced intermittent diastolic retroperfusion. This al- 
lowed effective delivery of arterial blood in diastole yet 
maintained a normal pattern of systolic venous drainage. 
Over the years that followed, the technique’s efficacy in 
reducing ischemic njury by enhancing washout of ischemic 
metabolites and perfusing ischemic myocardium was vali- 
dated in the anima! model (28-38). This provided the basis 
for the ren’ewed nthusiasm that led to the early clinical trials 
exploring tbe safety and efficacy of retrograde p rfusion i  
the se!!ing oi tinstable angina (39) and single-vessel coronary 
angioplasty (43). In more recent studies, Kar et al. (40) and 
Costantini etal. (41) documented the efficacy of retroperfu- 
sion support in failed and high risk angioplasty. Our study, 
involving higher retroperfusate flow rates and coronary sinus 
pressures in a large cohort with extensive disease, takes its 
place in this context. 
Four end points were used to assess the technique’s 
et?icacy: anginai variabies hemodynamics (exciuding coro- 
nary sinus pressures), ST segment shifts and echocardio- 
graphically defined wall motion abnormalities. D ff rences 
were noted between retroperfusion-supported and unsup- 
ported balloon inflations with regard to echocardiographic 
measurements. The ir:herently subjective nature of symp- 
toms makes quantification less reliable, although previous 
workers (40,41,43) described both delay in onset and atten- 
uation of angina1 severity with retroperfusion support. The 
only hemodynamic indexes evaluated in this study were 
heart rate and systolic and mean arterial blood pressures. 
The use of other variables, such as cardiac index and stroke 
work, as reported by Costantini’s group (41), might have 
increased our study’s sensitivity. Nevertheless, previous 
work has validated echocardiography and electrocardio- 
graphy as the most sensitive indicators of ischemia ssoci- 
ated with intermittent coronary artery occlusion during 
bakm angioplasty (47,X&55). The fact that ischemic ECG 
abnormalities are more sensitive and occur earlier than 
angina is well established (55). P;evir,us ~~vest~~ators have 
used either leads V, to V, or single-lea< ECG ~o~~t~~~~ 
(40,43). This study utilized continuous 12-lead EC 
toting. By this meth 
deviation between s 
was encountered despite the longer d~~rati~~ of the 
orted inflations. 
lthough as a group the cohort s 
coronary sinus retroperfusion, a high de 
variability in end points was encou 
may have bearing on this. The posi 
catheter within the core 
erable im~~~ta~ce. 
dium at risk in the 
trend toward incre 
the catheter was e 
achieve statistical 
of two earlier ~~vesti~to~s (40,43). 
The coronary sinus balloon must be 
provide optimal pressure augmentation 
tation of arterialize 
Coronary sinus anatomy varied consi 
study. After catheter seating, contrast 
a’#% stenosis nthe left anterior descending arter 
the coronary sinus at the time of angioplasty demonstrated 
venous conduits connecting the left marginal 
valve of Vieussens, wit 
anterior descending coronary 
artery lesion was successfully dilated. ~cbocardiograpbic 
assessment of wall motion showed only a limited retroper- 
fusion benefit. This luxurious network of venous anastomo- 
ses may have served to shunt oxygen-ric 
from the marginal to the posterior vein, 
anterior interventricuiar vein, thereby undermining the recb- 
nique’s effectiveness in supporting that erritory (35). 
The presence of smaller caliber venovenous connections 
beyond the level of angiographic detection can be inferred 
from a second case. In this patient (Case I) with a 90% 
mid-left circumflex coronary artery lesion and a target 90% 
mid-left anterior descending coronary artery lesion, the 
sinus catheter was inadvertently placed subselectively into 
the posterior vein of the left ventricle rather than the 
coronary sinus or great cardiac vein. Contrast venography 
opacified the posterior vein initially and, subsequently, both 
the posterior interventricular and anterior inte~ventric~lar 
veins opacified on a delayed basis. This linding s~~~ested the 
presence I apical venovenous conduits. Despite this 
catheter echocardiography demonstrated a satis- 
factory result in the left anterior descending coronary artery 
territory. although some :.eflux of retropetfusate into the 
coronary sinus cannot be excluded. Thus, these :4natomic 
variabilities might serve to enhance or undermine d llvery of 
JKC Vol. 22, No. I 
July 1993: 327-34 
rvenous ~oa~~e~tio~s. 
an vessels iratrQduce§ 
cardiac veins to
f the heart’s ven 
this extensive syste 
presence ofangiogra~~ica~~y 
e exp~ted to bear negatively 
of, and attenuating the severity of, ~~yocardial ischemia in 
the setting of moderate to high risk coronary angioplasty. 
~chocardiograp~ica~iy defined wall motion abnor 
were reduced in patients with ret 
sus ~nsu~~o~ed aogio~lasty ba 
uantified ST segment analysis howed no 
eviation g supported compared with uwsup 
ations de the sigRifica~t~y longer duration of 
inflations. The retrope 
C ications. Future directions 
C er delivery system, the ~~ve~o~~e~t 
other than arterial blood and improvement i  retroperfusate 
penetration bypilmp cycle modifications. 
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